Can TTR Assays Track Tafamidis Success in Cardiac Amyloidosis? Can TTR Assays Track Tafamidis Success in Cardiac Amyloidosis?

Pending a practical way to check whether costly tafamidis is working in individuals with TTR amyloid cardiopathy, transthyretin levels just might help as a surrogate efficacy endpoint, researchers propose.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news